<DOC>
	<DOCNO>NCT01420445</DOCNO>
	<brief_summary>The study conduct 4 comparative group orally treat YHD001 dose level 1 ( t.i.d . ) , YHD001 dose level 2 ( t.i.d . ) , pelargonium sidoides extract 9mL ( t.i.d . ) Placebo 7 day . The treatment assign randomly patient ( n=116 ) acute chronic bronchitis .</brief_summary>
	<brief_title>Safety/Tolerability Efficacy YHD001 Patients With Acute Chronic Bronchitis</brief_title>
	<detailed_description>The outcome measure evaluate overall change baseline end treatment score relate severity four symptom bronchitis : cough , sputum , QOL daily life , QOL fall asleep night .</detailed_description>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<criteria>Male female patient age ≥18 year Provision write informed consent Acute bronchitis Bronchitis Severity Score ( BSS ) ≥five point History clinically significant disease History drug/chemical/alcohol abuse Use antibiotic , antihistamine 7 day administration investigational product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>